Grace Therapeutics prices USD 10 million private placement at USD 2.1 per share - GRCE News | RalliesGrace Therapeutics prices USD 10 million private placement at USD 2.1 per share
G
GRCE• Grace Therapeutics prices private placement
- Grace Therapeutics priced a USD 10 million private placement of common stock, extending its cash runway to end-2028.
- The deal issues 4,761,904 shares at USD 2.1 each in an unregistered sale priced at-the-market under Nasdaq rules.
- Closing is expected Aug. 6, subject to customary conditions.
- Proceeds are earmarked for manufacturing and regulatory work to advance GTx-104, an injectable nimodipine formulation for IV infusion.
•
